ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,129Medicare Part D Prescriptions Filled, Including Refills

Rank: 248 out of 2588

$700K Total Retail Price of All Prescriptions

Rank: 231 out of 2588

711 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 711 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

19% of this provider’s 711 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,240 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 468 406 1 2
SIMVASTATIN 442 369 2 1
FUROSEMIDE 415 352 3 5
HYDROCODONE-ACETAMINOPHEN 377 205 S3 4 7
LISINOPRIL 341 293 5 3
METOPROLOL TARTRATE 294 274 6 9
OMEPRAZOLE 279 276 7 6
WARFARIN SODIUM 270 249 8 10
METFORMIN HCL 250 217 9 8
AMLODIPINE BESYLATE 230 219 10 4
NAMENDA 220 212 11 32
CITALOPRAM HBR 199 161 12 27
ATORVASTATIN CALCIUM 179 172 13 11
DONEPEZIL HCL 175 171 14 22
POTASSIUM CHLORIDE 168 158 15 15
PANTOPRAZOLE SODIUM 167 139 16 28
KLOR-CON M20 163 145 17 52
HYDROCHLOROTHIAZIDE 154 150 18 13
TRAMADOL HCL 140 123 19 19
CLOPIDOGREL 125 113 20 30
LANTUS 120 96 21 47
GABAPENTIN 119 81 22 18
LOSARTAN POTASSIUM 118 116 23 17
ALENDRONATE SODIUM 114 114 24 21
GLIMEPIRIDE 114 109 24 39
ATENOLOL 109 94 26 14
METOPROLOL SUCCINATE 106 101 27 12
AZITHROMYCIN 105 83 28 45
CIPROFLOXACIN HCL 103 88 29 82
ZOLPIDEM TARTRATE 100 43 30 24
DIGOXIN 99 94 31 38
TAMSULOSIN HCL 96 86 32 23
MIRTAZAPINE 90 77 33 63
PLAVIX 86 78 34 43
ALLOPURINOL 86 75 34 33
MELOXICAM 86 66 34 51
FAMOTIDINE 85 80 37 36
FENTANYL 83 50 S2 38 78
PREDNISONE 82 70 39 42
SERTRALINE HCL 81 80 40 26
NEXIUM 76 29 41 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 72 42 35
GLIPIZIDE 71 67 43 44
ESCITALOPRAM OXALATE 69 63 44 68
SPIRONOLACTONE 67 56 45 58
CRESTOR 66 59 46 25
ROPINIROLE HCL 65 43 47 113
LIDODERM 65 63 47 86
CYCLOBENZAPRINE HCL 63 29 R 49 87
POLYETHYLENE GLYCOL 3350 63 46 49 55
SPIRIVA 55 39 51 56
PRAVASTATIN SODIUM 54 40 52 16
VENTOLIN HFA 54 37 52 101
GLYBURIDE 53 42 R 54 65
LYRICA 52 32 55 100
DIOVAN 52 40 55 29
METOLAZONE 52 41 55 152
CARVEDILOL 51 39 58 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.